Julie Xing
Director/Board Member bei APTARGROUP, INC.
Vermögen: 227 778 $ am 31.03.2024
Profil
Julie Xing is currently the Executive Chairman at Mundipharma (China) Pharmaceutical Co., Ltd.
and an Independent Director at AptarGroup, Inc. She previously worked at Eli Lilly & Co. as the Senior Director-Global New Product Planning from 2010 to 2019.
Julie also held positions at Panomics LLC as the VP, GM-Asia Pacific & Japan Operations, and at Envista Holdings Corp.
as the Global Senior VP & President-Greater China.
She holds a doctorate degree from The Hong Kong University of Science & Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
APTARGROUP, INC.
0,00% | 08.03.2024 | 1 583 ( 0,00% ) | 227 778 $ | 31.03.2024 |
Aktive Positionen von Julie Xing
Unternehmen | Position | Beginn |
---|---|---|
APTARGROUP, INC. | Director/Board Member | 01.03.2023 |
Mundipharma (China) Pharmaceutical Co., Ltd.
Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Chairman | 01.03.2023 |
Ehemalige bekannte Positionen von Julie Xing
Unternehmen | Position | Ende |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2019 |
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
ENVISTA HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Julie Xing
The Hong Kong University of Science & Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
APTARGROUP, INC. | Process Industries |
ELI LILLY AND COMPANY | Health Technology |
ENVISTA HOLDINGS CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Commercial Services |
Mundipharma (China) Pharmaceutical Co., Ltd.
Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Health Technology |